|
HLX43 DOSE 2 (2.5 mg/kg) Clinical Trials
1 actively recruiting trial across 1 location
Houston, Texas1 trial
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
MD Anderson Cancer Hospital
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.